189 related articles for article (PubMed ID: 22740770)
61. C5aR1 Activation Drives Early IFN-γ Production to Control Experimental
Briukhovetska D; Ohm B; Mey FT; Aliberti J; Kleingarn M; Huber-Lang M; Karsten CM; Köhl J
Front Immunol; 2020; 11():1397. PubMed ID: 32733463
[No Abstract] [Full Text] [Related]
62. Protective role for interleukin-5 during chronic Toxoplasma gondii infection.
Zhang Y; Denkers EY
Infect Immun; 1999 Sep; 67(9):4383-92. PubMed ID: 10456878
[TBL] [Abstract][Full Text] [Related]
63. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
Nagineni CN; Pardhasaradhi K; Martins MC; Detrick B; Hooks JJ
Infect Immun; 1996 Oct; 64(10):4188-96. PubMed ID: 8926087
[TBL] [Abstract][Full Text] [Related]
64. Detection of Toxoplasma gondii in equine eyes.
Turner CB; Savva D
Vet Rec; 1991 Aug; 129(6):128. PubMed ID: 1926737
[No Abstract] [Full Text] [Related]
65. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
[TBL] [Abstract][Full Text] [Related]
66. [Immune response in mice induced by complex gene vaccine pcSAG1-ROP5 of Toxoplasma gondii].
Zhao HG; Fan ZG; Huang FY; Huang YH; Zhou SL; Lin YY; Tan GH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Feb; 31(1):1-5. PubMed ID: 24812827
[TBL] [Abstract][Full Text] [Related]
67. VEGF Production Is Regulated by the AKT/ERK1/2 Signaling Pathway and Controls the Proliferation of
Quan JH; Ismail HAHA; Cha GH; Jo YJ; Gao FF; Choi IW; Chu JQ; Yuk JM; Lee YH
Front Cell Infect Microbiol; 2020; 10():184. PubMed ID: 32432052
[TBL] [Abstract][Full Text] [Related]
68. Toxoplasma gondii protects against H(2)O(2) -induced apoptosis in ARPE-19 cells through the transcriptional regulation of apoptotic elements and downregulation of the p38 MAPK pathway.
Choi SH; Park SJ; Cha GH; Quan JH; Chang NS; Ahn MH; Shin DW; Lee YH
Acta Ophthalmol; 2011 Jun; 89(4):e350-6. PubMed ID: 21385331
[TBL] [Abstract][Full Text] [Related]
69. Modulated Gene Expression of
Zhou W; Quan JH; Gao FF; Ismail HAHA; Lee YH; Cha GH
Korean J Parasitol; 2018 Apr; 56(2):135-145. PubMed ID: 29742868
[TBL] [Abstract][Full Text] [Related]
70. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection.
Del Rio L; Bennouna S; Salinas J; Denkers EY
J Immunol; 2001 Dec; 167(11):6503-9. PubMed ID: 11714818
[TBL] [Abstract][Full Text] [Related]
71. Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis.
Feron EJ; Klaren VN; Wierenga EA; Verjans GM; Kijlstra A
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3228-32. PubMed ID: 11726627
[TBL] [Abstract][Full Text] [Related]
72. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice.
Lu F; Huang S; Hu MS; Kasper LH
Infect Immun; 2005 Aug; 73(8):5160-5. PubMed ID: 16041033
[TBL] [Abstract][Full Text] [Related]
73. The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1.
Lima KM; Vago JP; Caux TR; Negreiros-Lima GL; Sugimoto MA; Tavares LP; Arribada RG; Carmo AAF; Galvão I; Costa BRC; Soriani FM; Pinho V; Solito E; Perretti M; Teixeira MM; Sousa LP
J Biol Chem; 2017 Aug; 292(33):13758-13773. PubMed ID: 28655761
[TBL] [Abstract][Full Text] [Related]
74. Ocular and encephalic toxoplasmosis in canaries.
Williams SM; Fulton RM; Render JA; Mansfield L; Bouldin M
Avian Dis; 2001; 45(1):262-7. PubMed ID: 11332494
[TBL] [Abstract][Full Text] [Related]
75. Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice.
Marshall AJ; Brunet LR; van Gessel Y; Alcaraz A; Bliss SK; Pearce EJ; Denkers EY
J Immunol; 1999 Aug; 163(4):2089-97. PubMed ID: 10438948
[TBL] [Abstract][Full Text] [Related]
76. Congenital toxoplasmic retinochoroiditis in a mouse model.
Hay J; Lee WR; Dutton GN; Hutchison WM; Siim JC
Ann Trop Med Parasitol; 1984 Apr; 78(2):109-16. PubMed ID: 6742924
[TBL] [Abstract][Full Text] [Related]
77. Specific IgM, IgG and IgG1 directed against Toxoplasma gondii detected by flow cytometry and their potential as serologic tools to support clinical indirect fundoscopic presumed diagnosis of ocular disease.
Martins LM; Rangel ALP; Peixe RG; Silva-Dos-Santos PP; Lemos EM; Martins-Filho OA; Bahia-Oliveira LMG
J Immunol Methods; 2015 Feb; 417():97-106. PubMed ID: 25527345
[TBL] [Abstract][Full Text] [Related]
78. Exacerbation of toxoplasmosis in neutrophil-depleted mice.
Sayles PC; Johnson LL
Nat Immun; 1996-1997; 15(5):249-58. PubMed ID: 9390274
[TBL] [Abstract][Full Text] [Related]
79. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
Scharton-Kersten T; Caspar P; Sher A; Denkers EY
Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760
[TBL] [Abstract][Full Text] [Related]
80. Apoptosis within mouse eye induced by Toxoplasma gondii.
Hu S; Schwartzman JD; Kasper LH
Chin Med J (Engl); 2001 Jun; 114(6):640-4. PubMed ID: 11780444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
